Classification of Substrates and Inhibitors of P-Glycoprotein Using Unsupervised Machine Learning Approach
暂无分享,去创建一个
Ling Yang | Yan Li | Yong-Hua Wang | Sheng-Li Yang | Yonghua Wang | Yan Li | Ling Yang | Sheng-Li Yang
[1] Ying Xue,et al. Prediction of P‐Glycoprotein Substrates by a Support Vector Machine Approach. , 2004 .
[2] Samuel Kaski,et al. Visualizing the Clusters on the Self-Organizing Map , 1994 .
[3] Y. Shao,et al. Co-operative, competitive and non-competitive interactions between modulators of P-glycoprotein. , 1996, Biochimica et biophysica acta.
[4] Jung-Han Kim,et al. Capillary electrophoretic profiling and pattern recognition analysis of urinary nucleosides from thyroid cancer patients , 2003 .
[5] Yan Li,et al. Comparison of steroid substrates and inhibitors of P-glycoprotein by 3D-QSAR analysis , 2005 .
[6] Lutz Schmitt,et al. Structure and mechanism of ABC transporters. , 2002, Current opinion in structural biology.
[7] Erik Evensen,et al. A computational ensemble pharmacophore model for identifying substrates of P-glycoprotein. , 2002, Journal of medicinal chemistry.
[8] Tatiana Nikolskaya,et al. Modeling of human cytochrome p450-mediated drug metabolism using unsupervised machine learning approach. , 2003, Journal of medicinal chemistry.
[9] D K Yu,et al. The Contribution of P‐glycoprotein to Pharmacokinetic Drug‐Drug Interactions , 1999, Journal of clinical pharmacology.
[10] Mohammad Bagher Menhaj,et al. Training feedforward networks with the Marquardt algorithm , 1994, IEEE Trans. Neural Networks.
[11] I K Pajeva,et al. Structure-activity relationships of multidrug resistance reversers. , 2001, Current medicinal chemistry.
[12] L. Bain,et al. Structure-activity relationships for xenobiotic transport substrates and inhibitory ligands of P-glycoprotein. , 1997, Environmental health perspectives.
[13] S. Ekins,et al. Three-dimensional quantitative structure-activity relationships of inhibitors of P-glycoprotein. , 2002, Molecular pharmacology.
[14] A. Safa,et al. Identification and characterization of the binding sites of P-glycoprotein for multidrug resistance-related drugs and modulators. , 2004, Current medicinal chemistry. Anti-cancer agents.
[15] C. Dey,et al. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. , 2003, Pharmacological research.
[16] Kai Huang,et al. Feature reduction for improved recognition of subcellular location patterns in fluorescence microscope images , 2003, SPIE BiOS.
[17] V. Ling,et al. Positively cooperative sites for drug transport by P-glycoprotein with distinct drug specificities. , 1997, European journal of biochemistry.